283 related articles for article (PubMed ID: 24475144)
21. Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease.
Scheltens NME; Briels CT; Yaqub M; Barkhof F; Boellaard R; van der Flier WM; Schwarte LA; Teunissen CE; Attali A; Broersen LM; van Berckel BNM; Scheltens P
Alzheimers Dement (N Y); 2019; 5():492-500. PubMed ID: 31650005
[TBL] [Abstract][Full Text] [Related]
22. Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.
Cansev M; Turkyilmaz M; Sijben JWC; Sevinc C; Broersen LM; van Wijk N
J Alzheimers Dis; 2017; 59(1):301-311. PubMed ID: 28598848
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.
García-Alberca JM; Gris E; de la Guía P; Mendoza S; de la Rica ML
J Alzheimers Dis; 2023; 91(4):1459-1469. PubMed ID: 36641676
[TBL] [Abstract][Full Text] [Related]
24. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
[TBL] [Abstract][Full Text] [Related]
25. Effects of Rivastigmine on Brain Functional Networks in Patients With Alzheimer Disease Based on the Graph Theory.
Zhang J; Cheng J; Yang H
Clin Neuropharmacol; 2021 Jan-Feb 01; 44(1):9-16. PubMed ID: 33337622
[TBL] [Abstract][Full Text] [Related]
26. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
[No Abstract] [Full Text] [Related]
27. Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial.
Kamphuis PJ; Verhey FR; Olde Rikkert MG; Twisk JW; Swinkels SH; Scheltens P
J Nutr Health Aging; 2011 Aug; 15(8):672-6. PubMed ID: 21968863
[TBL] [Abstract][Full Text] [Related]
28. Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study.
Pardini M; Serrati C; Guida S; Mattei C; Abate L; Massucco D; Sassos D; Amore M; Krueger F; Cocito L; Emberti Gialloreti L
Neurodegener Dis; 2015; 15(1):58-62. PubMed ID: 25592742
[TBL] [Abstract][Full Text] [Related]
29. Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.
Scheltens NME; Kuyper IS; Boellaard R; Barkhof F; Teunissen CE; Broersen LM; Lansbergen MM; van der Flier WM; van Berckel BNM; Scheltens P
Alzheimers Dement (N Y); 2016 Nov; 2(4):233-240. PubMed ID: 29067310
[TBL] [Abstract][Full Text] [Related]
30. Cortical connectivity and memory performance in cognitive decline: A study via graph theory from EEG data.
Vecchio F; Miraglia F; Quaranta D; Granata G; Romanello R; Marra C; Bramanti P; Rossini PM
Neuroscience; 2016 Mar; 316():143-50. PubMed ID: 26724581
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial.
Kamphuis PJ; Verhey FR; Olde Rikkert MG; Twisk JW; Swinkels SH; Scheltens P
J Nutr Health Aging; 2011 Aug; 15(8):720-4. PubMed ID: 21968871
[TBL] [Abstract][Full Text] [Related]
33. Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data.
Vecchio F; Miraglia F; Marra C; Quaranta D; Vita MG; Bramanti P; Rossini PM
J Alzheimers Dis; 2014; 41(1):113-27. PubMed ID: 24577480
[TBL] [Abstract][Full Text] [Related]
34. Dynamic cortical connectivity alterations associated with Alzheimer's disease: An EEG and fNIRS integration study.
Li R; Nguyen T; Potter T; Zhang Y
Neuroimage Clin; 2019; 21():101622. PubMed ID: 30527906
[TBL] [Abstract][Full Text] [Related]
35. Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity.
Sanz-Arigita EJ; Schoonheim MM; Damoiseaux JS; Rombouts SA; Maris E; Barkhof F; Scheltens P; Stam CJ
PLoS One; 2010 Nov; 5(11):e13788. PubMed ID: 21072180
[TBL] [Abstract][Full Text] [Related]
36. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
37. A nutrient combination designed to enhance synapse formation and function improves outcome in experimental spinal cord injury.
Pallier PN; Poddighe L; Zbarsky V; Kostusiak M; Choudhury R; Hart T; Burguillos MA; Musbahi O; Groenendijk M; Sijben JW; deWilde MC; Quartu M; Priestley JV; Michael-Titus AT
Neurobiol Dis; 2015 Oct; 82():504-515. PubMed ID: 26388399
[TBL] [Abstract][Full Text] [Related]
38. Assessment of a Potential Synergistic Effect of Souvenaid® in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study.
Viñuela F; Barro A
J Alzheimers Dis; 2021; 80(4):1377-1382. PubMed ID: 33682712
[TBL] [Abstract][Full Text] [Related]
39. EEG time signature in Alzheimer´s disease: Functional brain networks falling apart.
Smailovic U; Koenig T; Laukka EJ; Kalpouzos G; Andersson T; Winblad B; Jelic V
Neuroimage Clin; 2019; 24():102046. PubMed ID: 31795039
[TBL] [Abstract][Full Text] [Related]
40. Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease Versus Vascular Dementia Diagnosis.
Vecchio F; Miraglia F; Alú F; Orticoni A; Judica E; Cotelli M; Rossini PM
J Alzheimers Dis; 2021; 82(2):871-879. PubMed ID: 34092648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
